The scientist’s investigation covers issues in Immunology, Eosinophil, Eosinophilia, Cell biology and Hypereosinophilic syndrome. His Eosinophil study combines topics from a wide range of disciplines, such as Molecular biology, Peripheral blood mononuclear cell, Cell–cell interaction and Interleukin 5. His Eosinophilia research is multidisciplinary, relying on both Immunopathology, Eosinophilic and In situ hybridization.
His Cell biology research includes themes of Receptor and Lipid metabolism. Peter F. Weller works mostly in the field of Lipid metabolism, limiting it down to topics relating to Inflammation and, in certain cases, Innate immune system and Tumor necrosis factor alpha, as a part of the same area of interest. His studies deal with areas such as Vasculitis, Clinical trial, Eosinophilic esophagitis and Intensive care medicine as well as Hypereosinophilic syndrome.
His primary areas of investigation include Immunology, Eosinophil, Cell biology, Biochemistry and Eosinophilia. His work in Hypereosinophilic syndrome, Immune system, Allergic inflammation, Antigen and Cytokine is related to Immunology. His Eosinophil research focuses on Molecular biology and how it relates to Antibody.
The Cell biology study combines topics in areas such as Inflammation and Secretion. His Secretion research includes elements of Chemokine, Vesicular transport protein, Secretory pathway and CCL11. He combines topics linked to Eosinophilic with his work on Eosinophilia.
The scientist’s investigation covers issues in Eosinophil, Cell biology, Immunology, Inflammation and Secretion. His work on Eosinophil cationic protein as part of general Eosinophil research is often related to Cytolysis, thus linking different fields of science. His research in Cell biology intersects with topics in Immunogold labelling and CCL11.
His work in Immunology is not limited to one particular discipline; it also encompasses Eosinophilic. His Inflammation study incorporates themes from Innate immune system, Immune system, Immunity and In vivo. His Secretion study also includes
His primary scientific interests are in Immunology, Eosinophil, Cell biology, Inflammation and Extracellular. As a part of the same scientific study, Peter F. Weller usually deals with the Immunology, concentrating on Secretion and frequently concerns with Chemokine. His work on Eosinophil cationic protein is typically connected to Cytolysis as part of general Eosinophil study, connecting several disciplines of science.
His Cell Compartmentation study, which is part of a larger body of work in Cell biology, is frequently linked to Tissue Embedding, bridging the gap between disciplines. His Inflammation research is multidisciplinary, incorporating elements of Lipid metabolism, Lipid droplet, Organelle and Innate immune system. His study looks at the relationship between Eosinophilia and topics such as Clinical trial, which overlap with Pharmacotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The idiopathic hypereosinophilic syndrome
Peter F. Weller;Glenn J. Bubley.
The immunobiology of eosinophils.
Peter F. Weller.
The New England Journal of Medicine (1991)
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
A Nicholson-Weller;J Burge;D T Fearon;P F Weller.
Journal of Immunology (1982)
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.
Peter Valent;Amy D. Klion;Hans-Peter Horny;Florence Roufosse.
The Journal of Allergy and Clinical Immunology (2012)
Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4
P F Weller;C W Lee;D W Foster;E J Corey.
Proceedings of the National Academy of Sciences of the United States of America (1983)
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
Marc E. Rothenberg;Amy D. Klion;Florence E. Roufosse;Jean Emmanuel Kahn.
The New England Journal of Medicine (2008)
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Michael E. Wechsler;Praveen Akuthota;David Jayne;Paneez Khoury.
The New England Journal of Medicine (2017)
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.
Princess U. Ogbogu;Bruce S. Bochner;Joseph H. Butterfield;Gerald J. Gleich.
The Journal of Allergy and Clinical Immunology (2009)
Bronchoconstrictor effects of leukotriene C in humans
JW Weiss;JM Drazen;N Coles;ER McFadden.
Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.
Amy D. Klion;Bruce S. Bochner;Gerald J. Gleich;Thomas B. Nutman.
The Journal of Allergy and Clinical Immunology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: